Aurisco Pharmaceutical Co.,Ltd

Aurisco Pharmaceutical Co., Ltd. is a distinguished manufacturer specializing in complex Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs), and comprehensive CRDMO (Contract Research, Development and Manufacturing Organization) services for oligonucleotide APIs. Since its establishment in 1998, Aurisco Pharmaceutical Co. has been dedicated to excellence in the pharmaceutical sector. Publicly listed on the Shanghai Stock Exchange since 2020 (stock code 605116), Aurisco Pharmaceutical Co. boasts a robust infrastructure, including three state-of-the-art factories and six advanced R&D centers.

With a workforce of over 1,300 employees, including approximately 240 dedicated R&D personnel, Aurisco Pharmaceutical Co. is at the forefront of innovation. The company excels in complex synthesis, synthetic biology, oligonucleotide synthesis, and photochemistry, positioning itself as a leader in these specialized fields. Aurisco Pharmaceutical Co. is headquartered in Shanghai, cn and has become a trusted, long-term partner to numerous world-renowned pharmaceutical companies, delivering high-quality products and efficient services worldwide.

Aurisco Pharmaceutical Co. is committed to maintaining an internationally compliant quality system and offers substantial production capacity to meet global demands. Through its extensive global sales network, Aurisco Pharmaceutical Co. ensures that customers receive unparalleled service and support. We invite the management team at Aurisco Pharmaceutical Co. to take the next step and create a customized and exclusive company showcase and product listing on our platform, further enhancing its visibility and commercial opportunities.